Discovery and development of sesquiterpenoid derived hydroxymethylacylfulvene: A new anticancer drug

Bioorganic and Medicinal Chemistry

Volumn 7, Issue 5, 1999, Pages 881-886

  McMorris, Trevor C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 HYDROXYMETHYLACYLFULVENE; ANTINEOPLASTIC AGENT; DOXORUBICIN; ILLUDIN S; IRINOTECAN; MITOMYCIN C; SESQUITERPENOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW TOXICITY; CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; DRUG SELECTIVITY; DRUG SYNTHESIS; FATIGUE; FLUSHING; HUMAN; MALE; METABOLIC ACTIVATION; MOUSE; NAUSEA; NEPHROTOXICITY; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PROSTATE CANCER; VOMITING;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CLINICAL TRIALS; HUMANS; MALE; MICE; MODELS, CHEMICAL; PROSTATIC NEOPLASMS; RATS; SESQUITERPENES; TECHNOLOGY, PHARMACEUTICAL; TUMOR CELLS, CULTURED;

EID: 0033135074     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(99)00016-4     Document Type: Article

References (44)

1. McMorris, T. C.; Kelner, M. J.; Wang, W.; Yu, J.; Estes, L. A.; Taetle, R. J. Nat. Prod. 1996, 59, 896.
2. Anchel, M.; Hervey, A.; Robbins, W. J. Proc. Natl. Acad. Sci. USA 1950, 36, 300.
3. MacDonald, J. R.; Muscoplat, C. C.; Dexter, D. L.; Mangold, G. L.; Chen, S.-F.; Kelner, M. J.; McMorris, T. C.; Von Hoff, D. D. Cancer Res. 1997, 57, 279.
4. National Cancer Institute Website: http://cancernet.nci.nih.gov/prot/pat/index.shtml.
5. Ammirati, J. F.; Traquair, J. A.; Horgen, P. A. Poisonous Mushrooms of the Northern United States and Canada: University of Minnesota Press: Minneapolis, 1985, p. 290.
6. Nakanishi, K.; Ohashi, M.; Tada, M.; Yamada, Y. Tetrahedron 1965, 21, 1231.
7. Matsumoto, T.; Shirahama, H.; Ichihara, A.; Fukuoka, Y.; Takahashi, Y.; Mori, Y.; Watanabe, M. Tetrahedron, 1965, 21, 2671.
8. McMorris, T. C.; Nair, M. S. R.; Singh, P.; Anchel, M. Phytochemistry 1971, 10, 1611.
9. Nair, M. S. R.; Takeshita, H.; McMorris, T. C.; Anchel, M. J. Org. Chem. 1969, 34, 240.
10. Ayer, W. A.; Browne, L. M. Tetrahedron 1981, 37, 2199.
11. Arnone, A.; Cardillo, R.; Nasini G.; Vajna de Pava, O. J. Chem. Soc. Perkin Trans. 1 1991, 733.
12. Harttig, U.; Anke, T.; Scherer, A.; Steglich, W. Phytochemistry 1990, 29, 3942.
13. McMorris, T. C.; Anchel, M. J. Am. Chem. Soc. 1963, 85, 831.
14. McMorris, T. C.; Kelner, M. J.; Chadha, R. K.; Siegel, J. S.; Moon, S.-S.; Moya, M. M. Tetrahedron 1989, 45, 5433.
15. Anchel, M.; McMorris, T. C.; Singh, P. Phytochemistry 1970, 9, 2339.
16. Hanson, J. R.; Marten, T. Chem. Soc., Chem. Commun. 1973, 171.
17. Kushida, T.; Uesugi, M.; Sugiura, Y.; Kigoshi, H.; Tanaka, H.; Hirokawa, J.; Ojika, M.; Yamada, K. J. Am. Chem. Soc. 1994, 116, 479.
18. Ng, K.-M. E.; McMorris, T. C. Can. J. Chem. 1984, 62, 1945.
19. McMorris, T. C.; Kelner, M. J.; Wang, W.; Moon, S.; Taetle, R. Chem. Res. Toxicol. 1990, 3, 574.
20. Tanaka, K.; Inoue, T.; Kadota, S.; Kikuchi T. Xenobiotica 1992, 22, 33.
21. McMorris, T. C.; Anchel, M. J. Am. Chem. Soc. 1965, 87, 1594.
22. Kelner, M. J.; McMorris, T. C.; Beck, W. T.; Zamora, J. M.; Taetle, R. Cancer Res. 1987, 47, 3186.
23. McMorris, T. C.; Kelner, M. J.; Wang, W.; Estes, L. A.; Montoya, M. A.; Taetle, R. J. Org. Chem. 1992, 57, 6876.
24. Kelner, M. J.; McMorris, T. C.; Taetle, R. Anticancer Res. 1995, 15, 873.
25. Weinreb, S. M.; McMorris, T. C.; Anchel, M. Tetrahedron Lett. 1971, 38, 3489.
26. McMorris, T. C.; Kelner, M. J.; Wang, W.; Diaz, M. A.; Estes, L. A.; Taetle, R. Experientia 1996, 52, 75.
27. Kelner, M. J.; McMorris, T. C.; Estes, L.; Starr, R. J.; Rutherford, M.; Montoya, M.; Samson, K. M.; Taetle, R. Cancer Res. 1995, 55, 4936.
28. Kelner, M. J.; McMorris, T. C.; Estes, L.; Wang, W.; Samson, K. M.; Taetle, R. Investigational New Drugs 1996, 14, 161.
29. Marty, J.; MacDonald, J.; Mangold, G.; Weitman, S.; Von Hoff, D. Evidence of synergistic antitumor activity with MGI 114 in combination with Irinotecan (ITN) or 5-Fluorouracil (5-FU) against a human colon tumor xenograft model. 89th Annual American Meeting for Cancer Research, 1998; Abstract No. 3585.
30. McMorris, T. C.; Yu, J.; Estes, L. A.; Kelner, M. J. Tetrahedron 1997, 53, 14579.
31. Matsumoto, T.; Shirahama, H.; Ichihara, A.; Shin, H.; Kagawa, S.; Sakan, F. Tetrahedron Lett. 1970, 14, 1171.
32. Matsumoto, T.; Shirahama, H.; Ichihara, A.; Shin, H.; Kagawa, S.; Sakan, F.; Miyano, K. Tetrahedron Lett. 1971, 23, 2049.
33. Padwa, A.; Curtis, E. A.; Sandanayaka, V. P. J. Org. Chem. 1997, 62, 1317.
34. Kinder, F. R.; Bair, K. W. J. Org. Chem. 1994, 59, 6965.
35. Kinder, F. R.; Wang, R. M.; Bauta, W. E.; Bair, K. W. Bioorg. Med. Chem. Lett. 1996, 6, 1029.
36. McMorris, T. C.; Hu, Y.; Yu, J.; Kelner, M. J. Chem. Commun. 1997, 315.
37. McMorris, T. C.; Yu, J.; Hu, Y.; Estes, L. A.; Kelner, M. J. J. Org. Chem. 1997, 62, 3015.
38. McMorris, T. C.; Yu, J.; Herman, D. M.; Kelner, M. J.; Dawe, R.; Minamida, A. J. Labelled Compounds and Radiopharmaceuticals 1998, XLI, 279.
39. Tanaka, K.; Inoue, T.; Tezuka, Y.; Kikuchi, T. Xenobiotica 1996, 26, 347.
40. McMorris, T. C.; Elayadi, A. N.; Yu, J.; Kelner, M. J. Biochem. Pharmacol. 1999, 57, 83.
41. Kelner, M. J.; McMorris, T. C.; Taetle, R. J. Natl. Cancer Inst. 1990, 82, 1562.
42. Kelner, M. J.; McMorris, T. C.; Estes, L.; Samson, K. M.; Bagnell, R. D.; Taetle, R. Eur. J. Cancer 1998, 34, 908.
43. Kelner, M. J.; McMorris, T. C.; Estes, L.; Rutherford, M.; Montoya, M.; Goldstein, J.; Sampson, K.; Starr, R.; Taetle, R. Biochem. Pharmacol 1994, 48, 403.
44. Woynarowski, J. M.; Napier, C.; Koester, S. K.; Chen, S.-F.; Troyer, D.; Chapman, W.; MacDonald, J. R. Biochem. Pharm. 1997, 54, 1181.